CALYPSO
The CALYPSO study applies to people who have chronic hypoparathyroidism. The study will test a new investigational medication, called eneboparatide, to learn its effects and how safe it is for people with low or absence of parathyroid hormone levels.
NIFTy
The NIFTy study is open to people who are having thyroid surgery. Its aim is to find out whether using near-infrared fluorescence imaging could reduce the number of people whose parathyroid glands become damaged during thyroid surgery.